NCT01283698 - Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Psoriasis

Interventions

DRUG

Experimental: LAS 41004 dosage 1

dosage 1, once daily

DRUG

Experimental: LAS 41004 dosage 2

LAS 41004 dosage 2, once daily

DRUG

Experimental: LAS 41004 dosage 3

dosage 3, once daily

DRUG

Placebo Comparator: placebo

once daily

DRUG

Reference

Active Comparator,once daily

Trial Locations (1)

Almirall Investigational Sites#1, Mahlow